EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Systemic Immune-Inflammation Index as a Predictor of Progression in Melanoma: A Retrospective Cohort Study

Ana G Perez-Romero, Martha A Aceves Villalvazo, Arcelia Y Figueroa Martínez, Monica P Ramos Alvarez

Cureus · 19.10.2025

DOI: 10.7759/cureus.94939 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cureus, erschienen am 19.10.2025. Verfasst von Ana G Perez-Romero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Hospital Regional "Dr. Valentín Gómez Farías" Institute for Social Security and Services for State Workers (ISSSTE), Zapopan, MEX. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Systemic inflammation plays a pivotal role in melanoma progression through mechanisms of immune suppression, angiogenesis, and metastatic dissemination. The systemic immune-inflammation index (SII), integrating platelet, neutrophil, and lymphocyte counts, has emerged as a composite biomarker reflecting the balance between tumor-promoting inflammation and host immune response. OBJECTIVE: This study aimed to evaluate the prognostic value of the SII in predicting 12-month progression-free survival (PFS) in patients with melanoma and to determine whether elevated SII independently correlates with disease progression after adjustment for clinical stage and age. METHODS: A retrospective cohort study was conducted, including 40 patients with histopathologically confirmed melanoma between 2019 and 2024. Baseline SII was calculated as (platelet count × neutrophil count) / lymphocyte count, using a validated cutoff of 560. Statistical analyses were performed using Jamovi version 2.4. Associations between SII and 12-month outcomes were assessed using chi-square and logistic regression analyses, while Kaplan-Meier and ROC analyses evaluated prognostic performance. RESULTS: An SII ≥560 was significantly associated with higher progression risk (relative risk (RR) 5.3; odds ratio (OR) 22.7, 95% confidence interval (CI) 4.4-117.5; p < 0.001). Patients with elevated SII had markedly reduced 12-month PFS (20% vs. 85%; log-rank = 16.5, p < 0.001). SII showed excellent discriminative ability (area under the curve (AUC) 0.91, 95% CI 0.83-0.99). In multivariable analysis, SII remained independently predictive of progression (adjusted OR 14.6; 95% CI 2.3-91.8; p = 0.004). CONCLUSION: The SII independently predicted 12-month disease progression in melanoma, identifying high-risk patients even within early stages. These findings support its role as a simple, reproducible, and low-cost biomarker for preoperative risk assessment and individualized follow-up. Future prospective multicenter studies with larger cohorts and extended follow-up are warranted to validate these results and to better define the clinical utility of SII as part of comprehensive melanoma risk stratification strategies.

Schlagwörter

Stichwörter der Autor:innen

melanomaprognostic biomarkerprogression-free survivalrisk stratificationsystemic immune-inflammation index (sii)

Autor:innen und Institutionen

  • Dermatology, Hospital Regional "Dr. Valentín Gómez Farías" Institute for Social Security and Services for State Workers (ISSSTE), Zapopan, MEX.
  • Dermatology, Dermika, Centro Dermatológico Laser, Guadalajara, MEX.

Zitieren

APA

Perez-Romero, A. G., Aceves Villalvazo, M. A., Figueroa Martínez, A. Y., & Ramos Alvarez, M. P. (2025). Systemic Immune-Inflammation Index as a Predictor of Progression in Melanoma: A Retrospective Cohort Study. Cureus. https://doi.org/10.7759/cureus.94939

Vancouver

Perez-Romero AG, Aceves Villalvazo MA, Figueroa Martínez AY, Ramos Alvarez MP. Systemic Immune-Inflammation Index as a Predictor of Progression in Melanoma: A Retrospective Cohort Study. Cureus. 2025. doi:10.7759/cureus.94939

BibTeX
@article{PerezRomero2025,
  author = {Perez-Romero, Ana G and Aceves Villalvazo, Martha A and Figueroa Martínez, Arcelia Y and Ramos Alvarez, Monica P},
  title = {Systemic Immune-Inflammation Index as a Predictor of Progression in Melanoma: A Retrospective Cohort Study},
  journal = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.94939}
}
Kostenlos starten →